ChemBriefEuropean Shares Rise as Genmab Surges on AbbVie Drug Trial Results
European stocks rose near one-week highs led by Genmab, which surged 7.6% after positive late-stage trial results for its blood cancer drug combo with AbbVie. The healthcare sector advanced as bond yi
reuters · 2026-10-06 00:34 UTC